About MeMed
MeMed is a company based in Tirat Carmel (Israel) founded in 2009 by Kfir Oved and Eran Eden.. MeMed has raised $163 million across 10 funding rounds from investors including OurCrowd, Foxconn Electronics and Social Capital. MeMed offers products and services including MeMed BV and MeMed Key. MeMed operates in a competitive market with competitors including Prenetics, Inflammatix, Visby Medical, GenMark Diagnostics and Molbio Diagnostics, among others.
- Headquarter Tirat Carmel, Israel
- Founders Kfir Oved, Eran Eden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Memeds Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$163 M (USD)
in 10 rounds
-
Latest Funding Round
$93 M (USD), Series D
Jan 10, 2022
-
Investors
OurCrowd
& 21 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MeMed
MeMed offers a comprehensive portfolio of products and services, including MeMed BV and MeMed Key. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
15-minute assay to differentiate bacterial and viral infections for better treatment.
Compact device for quick, multiplexed protein measurements in clinical settings.
Unlock access to complete
Unlock access to complete
Funding Insights of MeMed
MeMed has successfully raised a total of $163M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $93 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $93.0M
-
First Round
First Round
(23 Jul 2015)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series D - MeMed | Valuation | Shavit Capital , Union Tech Ventures | |
| Jan, 2020 | Amount | Grant - MeMed | Valuation |
investors |
|
| Nov, 2019 | Amount | Grant - MeMed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MeMed
MeMed has secured backing from 22 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include OurCrowd, Foxconn Electronics and Social Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Horizons Ventures is focused on investing in deep science and technology.
|
Founded Year | Domain | Location | |
|
Private equity investments in Israel are managed by Shavit Capital.
|
Founded Year | Domain | Location | |
|
US focused VC firm investing in seed & growth stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MeMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MeMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Memed Comparisons
Competitors of MeMed
MeMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Visby Medical, GenMark Diagnostics and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Memed
Frequently Asked Questions about MeMed
When was MeMed founded?
MeMed was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Where is MeMed located?
MeMed is headquartered in Tirat Carmel, Israel. It is registered at Tirat Carmel, Haifa District, Israel.
Who is the current CEO of MeMed?
Eran Eden is the current CEO of MeMed. They have also founded this company.
Is MeMed a funded company?
MeMed is a funded company, having raised a total of $163M across 10 funding rounds to date. The company's 1st funding round was a Grant of $2.76M, raised on Jul 23, 2015.
What does MeMed do?
MeMed Diagnostics provides machine learning-based diagnostic solutions for infectious diseases. The companys lead product ImmunoXpert, distinguishes between bacterial and viral infections based on the patients immune response in-vitro diagnostic test. The company also offers ImmunoPoC, a device for distinguishing between bacterial and viral infections at the point-of-care. The company also provides its immunoassay platform MeMed Key. Its solution also diagnoses infections inaccessible for direct pathogen sampling and avoids false alarms due to the presence of non-pathogenic bacteria and viruses.
Who are the top competitors of MeMed?
MeMed's top competitors include Visby Medical, Inflammatix and Prenetics.
What products or services does MeMed offer?
MeMed offers MeMed BV and MeMed Key.
Who are MeMed's investors?
MeMed has 22 investors. Key investors include OurCrowd, Foxconn Electronics, Social Capital, Ping An, and European Commission.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.